Skip to main content

Table 1 Characteristics of UFO study participants participating in the Rapid HCV testing study: (1) overall; and (2) in association with having chosen the rapid HCV test

From: Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs

Characteristic Overall (N = 129) Rapid test (N = 107) Standard blood draw (N = 22) P-value1
  N N (%) N (%)  
Median age (range, IQR)[yrs] 25 (23–27) 25 (23–27) 25 (23–27) 0.75
Gender     
 Male 88 72 (81.8) 16 (18.2) 0.80
 Female 40 34 (85.0) 6 (15.0)  
Ethnicity     
 Non-white 55 48 (87.3) 7 (12.7) 0.35
 White 74 59 (79.7) 15 (20.3)  
Ethnicity     
 Asian, Asian-American 1 1 (100) 0 (0) 0.56
 African American 5 4 (80.0) 1 (20.0)  
 Filipino 1 1 (100) 0 (0)  
 Latino/Hispanic 7 6 (85.7) 1 (14.3)  
 Native American 5 3 (60.0) 2 (40.0)  
 Caucasian 74 59 (79.7) 15 (20.3)  
 Other 9 8 (88.9) 1 (11.1)  
 Mixed 27 25 (92.6) 2 (7.4)  
Previously tested for HIV     
 Yes 105 86 (81.9) 19 (18.1) 1.00
 No 21 18 (85.7) 3 (14.3)  
 Missing* 3   3  
Self report anti-HIV results     
 Negative 101 83 (82.2) 18 (17.8) 1.00
 Positive 5 4 (80.0) 1 (20.0)  
Homeless, last 3 months     
 Yes 101 82 (81.2) 19 (18.8) 0.40
 No 28 25 (89.3) 3 (10.7)  
Completed grade 12     
 Yes 93 78 (83.9) 15 (16.1) 0.79
 No 36 29 (80.6) 7 (19.4)  
Seen health provider, last 3 months     
 Yes 64 52 (81.3) 12 (18.8) 0.82
 No 64 54 (84.4) 10 (15.6)  
 Missing* 1   1  
Obtained new needles from NEP, last 3 months     
 Yes 95 77 (81.1) 18 (19) 0.43
 No 33 29 (87.9) 4 (12.1)  
 Missing* 1   1  
Median years injecting (range, IQR)[yrs] 4.2 (1.7-7.5) 4 (1.5-7.7) 4.9 (2.1-6.5) 0.51
Inject every day in past 30 days     
 Yes 37 29 (78.4) 8 (21.6) 0.44
 No 91 77 (84.6) 14 (15.4)  
 Missing* 1   1  
  1. *Missing values were not factored into the proportions or p-values presented.
  2. 1Fisher’s Exact Test for frequency and Kruskal-Wallis Test for median value comparison.